HR 7032 · 117th Congress · Health

Increasing Transparency in Generic Drug Applications Act of 2022

Introduced 2022-03-09· Sponsored by Rep. Kuster, Ann M. [D-NH-2]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2022-03-10)

Plain Language Summary

[AI summary unavailable — showing source text] Increasing Transparency in Generic Drug Applications Act of 2022 This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Democrat
Rep. Schrier, Kim [D-WA-8]WA